Drug recall · March 22, 2023
Clear Eyes recall
Why: Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%, Antihistamine, 2.5 mL (0.085 fl oz) bottle, Sterile, Distributed by Medtech Products Inc. Tarrytown, NY 10591, A Prestige Consumer Healthcare company, Made in Israel, UPC 678112000708; NDC 67172-504-01.
- Lots / codes
Lot #114349, Exp. 05/2023; 117396, Exp. 09/2023; 120128, Exp. 11/2023; 114371, Exp. 06/2023; 123781, Exp. 02/2024.
- Quantity
- 715,632 bottles
- Company
- Teva Pharmaceuticals USA Inc, Parsippany, NJ
- Distribution
- Nationwide in the U.S.A.
- Initiated
- February 23, 2023 · Voluntary: Firm initiated
- Classified
- March 20, 2023
- Reported
- March 22, 2023
- Ended
- November 28, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Olopatadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.